NEUROUROLOGY AND URODYNAMICS is a prestigious peer-reviewed journal published by WILEY, focusing on the intersection of neurology and urology. Since its inception in 1982, this journal has developed a strong reputation, evidenced by its impressive Q2 rankings in both the neurology (clinical) and urology categories as of 2023. With a Scopus rank of #38 out of 120 in Medicine (Urology) and #184 out of 400 in Medicine (Neurology), it occupies a significant position in the academic landscape, casting light on the complex interactions between the nervous and urinary systems. Although the journal does not currently offer open access options, it remains a critical resource for researchers, clinicians, and students seeking to advance their understanding of urodynamics and neurological disorders impacting urological health. With its broad scope and commitment to advancing scientific discourse, NEUROUROLOGY AND URODYNAMICS continues to be an essential publication in enhancing the global dialogue within these interrelated fields.

Urology Practice is a distinguished journal dedicated to advancing knowledge and practice in the field of urology. Published by Lippincott Williams & Wilkins, this journal has been pivotal in providing a platform for the dissemination of innovative research and clinical findings since its inception in 2014. With an ISSN of 2352-0779 and an E-ISSN of 2352-0787, the journal is indexed in Scopus, ranking #73 out of 120 in the Urology category, placing it in the 39th percentile. As part of the Q3 quartile in Urology for 2023, Urology Practice contributes significantly to the evolving landscape of urological medicine, offering vital insights to researchers, healthcare professionals, and students alike. While currently not an open-access journal, its valuable content remains accessible through traditional subscription-based models, catering to a global audience keen on enhancing their expertise in urology. The journal's commitment to excellence and its rigorous peer-review process ensure that published articles uphold the highest standards of scientific integrity, making it an essential resource for those engaged in urological research and clinical practice.

Urology Journal, published by the UROL & NEPHROL RES CTR-UNRC, is a pivotal open-access platform dedicated to advancing the field of urology since 2004. With a visible commitment to disseminating high-quality research, this journal plays a significant role in enhancing global knowledge and practices in urological health. With an impact factor reflective of its continuous growth, the journal has achieved a commendable position in the Scopus rankings, landing within the 46th percentile for urology. Operating out of Iran, the journal addresses a wide variety of topics pertinent to urological studies, making it invaluable for researchers, clinicians, and students in the field. The journal operates under the open-access model, ensuring that critical findings are available to a broader audience, thereby fostering collaboration and furthering education within the urology community. Whether you are keen on contemporary studies or emerging trends, Urology Journal serves as an essential resource for fostering academic dialogue and innovation in urology.

The Journal of Urology stands as a premier publication in the field of urology, dedicated to advancing the understanding and treatment of urological diseases. Published by Lippincott Williams & Wilkins, this esteemed journal has maintained a strong presence since its inception in 1945, converging research and clinical practice until 2024. With an impressive impact factor that underscores its relevance and influence in the field—ranking 4th out of 120 in Urology according to Scopus—this journal is a vital resource for clinicians, researchers, and students alike. As a Q1 journal in its category for 2023, it boasts a high degree of visibility and rigorous peer-review standards, making it an essential reading for those wishing to stay abreast of the latest discoveries and technological advancements in urological health. Although it does not offer open access, the journal's commitment to disseminating high-quality research ensures its continued impact on both the academic community and clinical practice.

Current Urology, published by Lippincott Williams & Wilkins, is a leading journal dedicated to advancing the fields of urology, oncology, and reproductive medicine. With an ISSN of 1661-7649 and E-ISSN of 1661-7657, this journal has established itself as a valuable resource for researchers, practitioners, and students alike, providing peer-reviewed articles that contribute to the ongoing discourse and development of these critical specialties. Operating out of the United States, Current Urology ranks in the third quartile for oncology, reproductive medicine, and urology, reflecting its importance in the medical community. The journal’s focus on innovative research and clinical practice allows it to bridge gaps between theoretical understanding and practical application, enhancing patient care and outcomes. Although currently not an open-access journal, it offers a wealth of insights and findings that underpin contemporary urological practices and research. In an evolving medical landscape, Current Urology remains an essential platform for disseminating knowledge and fostering collaboration among experts in the field.

European Urology Oncology is a premier academic journal dedicated to advancing the field of urological oncology through innovative research and interdisciplinary collaboration. Published by Elsevier and based in the Netherlands, this journal runs on the principles of providing high-quality, peer-reviewed content that meets the evolving needs of professionals in medicine, surgery, and oncology. With an impressive 2023 categorization in the Q1 quartiles across multiple disciplines including Medicine (Miscellaneous), Oncology, and Urology, the journal demonstrates its pivotal role in disseminating essential findings that enhance clinical practices. The E-ISSN of this journal is 2588-9311, ensuring accessibility to groundbreaking articles that influence treatment methodologies and patient outcomes. Researchers and professionals relying on the latest evidence in urology and oncology will find this journal essential for keeping abreast of cutting-edge developments and clinical insights that shape the future of healthcare.

UROLOGY is a prestigious journal published by Elsevier Science Inc, renowned for disseminating high-quality research and reviews in the field of urology. With an ISSN of 0090-4295 and E-ISSN 1527-9995, this journal has been a trusted resource since its inception in 1973 and continues to provide insights into the latest advancements and clinical practices in urology, maintaining a category quartile of Q2 as of 2023. The journal ranks 50th out of 120 in the Scopus metrics for Medicine - Urology, placing it in the 58th percentile, which underscores its influence and relevance in the academic community. Although it is not structured as an open access journal, it offers a wealth of knowledge vital for researchers, healthcare professionals, and students alike, enabling them to stay abreast of evolving treatments and innovations in the field. As we move towards 2024, UROLOGY remains committed to advancing research and enhancing practices in urological care, fostering a collaborative environment among its readership.

Journal of Pediatric Urology is a leading academic journal dedicated to the intersection of pediatric medicine and urological science. Published by ELSEVIER SCI LTD, this esteemed journal provides a vital platform for the dissemination of innovative research and clinical advancements in the field. With a 2023 impact factor that places it within the Q2 quartile for Pediatrics, Perinatology and Child Health, and the Q1 quartile for Urology, it is recognized among the top-tier journals in both domains. The journal covers a broad spectrum of topics from minimally invasive surgical techniques to management strategies for congenital urological disorders. This makes it an invaluable resource for researchers, clinicians, and students who seek to improve pediatric urological care. As the journal continues to evolve, it aims to foster interdisciplinary collaboration that drives further advancements in pediatric health. For those looking to avoid publication barriers, the journal retains traditional access options while contributing to the global growth of pediatric urology research from its base in the Netherlands.

Urologic Oncology - Seminars and Original Investigations is a premier journal published by Elsevier Science Inc, dedicated to advancing the field of urologic oncology through high-quality, peer-reviewed research and insightful scholarly discussions. With an ISSN of 1078-1439 and an E-ISSN of 1873-2496, this journal has established itself as a vital resource for professionals, researchers, and students alike since its inception in 1995. Currently holding a Q2 ranking in Oncology and a prestigious Q1 in Urology for 2023, it ranks 28th out of 120 in Urology and 177th out of 404 in Oncology within Scopus, underscoring its relevance and impact in these critical fields. While the journal operates under a subscription model, it continues to deliver compelling and transformative research aimed at enhancing patient outcomes in urologic oncology. With a focus on innovative therapies, diagnostic advancements, and clinical trials, the journal contributes significantly to ongoing dialogue and development in urologic health care.

Canadian Journal of Urology, published by CANADIAN J UROLOGY, is a prominent peer-reviewed journal dedicated to advancing the field of urology and its allied disciplines. Established in 2000, this journal has consistently aimed to provide a platform for comprehensive research, clinical studies, and innovative practices in urology and general medicine, ensuring that professionals remain at the forefront of medical advancements. With a reputation reflected in its 2023 Scopus ranking of Q3 in both Urology and Medicine (miscellaneous), the journal serves as an essential resource for researchers and practitioners seeking to enhance their knowledge and application of urological sciences. Although it is not an Open Access journal, its impactful findings contribute significantly to the medical community in Canada and beyond, promoting evidence-based practices and contributing to better patient outcomes. As the journal converges into 2024, it continues to welcome high-quality submissions that explore critical challenges and advancements in urology.